Diabetes mellitus type 1 treated with insulin pump Nutritional, Metabolic, Endocrine Insulin-dependent diabetes mellitus
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Diabetes mellitus type 1 treated with continuous subcutaneous insulin infusion (CSII) for a minimum of 6 months 2. Age: 18-75, either sex 3. Willing and able to sign informed consent
Exclusion criteria
Exclusion criteria: 1. Impaired awareness of hypoglycaemia according to Gold [7] and / or Clarke [8] method 2. Body mass index (BMI) > 35 kg/m2 3. Glycated haemoglobin (HbA1c) > 11.0% 4. Use of heparin, coumarin derivatives or oral corticosteroids 5. Skin condition prohibiting needle insertion 6. Pregnancy and/or breastfeeding 7. Any condition that the local investigator feels would interfere with trial participation or the evaluation of results
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To assess the efficacy of the closed loop system, defined as the time spent in euglycemia. Euglycemia is defined as glucose concentration between 3.5 mmol/l -10 mmol/l. The proportions of time spent in eu-, hypo and hyperglycaemia in closed loop will be compared to open loop. Time points of measurement are the last 48 hours divided in first 24 hours and last 24 hours. Furthermore to analyze for a meal and three hours postprandial Night: from 00.00 till 7.00 AM | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Difference in overall mean sensor glucose comparing closed loop system to open loop 2. Difference in postprandial, post exercise and night sensor glucose excursions measured as area under the curve comparing closed loop to open loop 3. Difference in numbers of hypoglycaemias (glucose at or below 3.5 mmol/l) comparing the closed loop to open loop Time points of measurement are the last 48 hours divided in first 24 hours and last 24 hours. Furthermore to analyze for a meal and three hours postprandial Night: from 00.00 till 7.00 AM | — |
Countries
Netherlands